The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Baffled. Falling on good news!
Why so much ?? anyone got a theory or know anything
No doubt NVG will pop up and tell us all this is grossly overvalued and that he will get in when it drops back into the 800’s. LOL
Yes.
This sounds to be particularly good news..
Consistent strategy.
Seems to be back on the march ( st leger day )
Https://www.lse.co.uk/news/AZN/update-astrazeneca-has-good-results-from-three-cancer-drugs-in-trials-1mtuvvrrouuggwu.html versus Soirot news. MM shenanigans
Many thanks for this info.
Probably the news yesterday the CEO maybe leaving the company?
https://www.thisismoney.co.uk/money/markets/article-12498983/AstraZeneca-boss-Sir-Pascal-Soriot-looks-step-down.html
Does anyone know why did the share price fall today?
The clinical trials results seemed to be fine.
It seems to me that Governments around the world are wrestling with increasingly expensive medications that the people and doctors want to access via public healthcare.
China has its national drug reimbursement list with large discounts to give access to the heatlthcare hospital pharmacies and state funding.
The UK imposes a levy on manufacturers to compensate for increasing costs of drugs
The US seems to be behind the curve….in paying what the manufacturer demands rather than negotiating a lower price to be on the government list….
It does seem to me that pharma may become slightly less profitable….but that may depend on what will the industry be able to claw back through higher charges to non government revenue streams? Or what other concessions it may be able to wring out of the politicians.
Https://www.proactiveinvestors.co.uk/companies/news/1022687/astrazeneca-is-a-premium-growth-story-says-broker-1022687.html
the wizard....your 13 years,out of date
After reading the 2010 paper, I suggest dumping this stock and finding a company that is capable of developing thiazolidinedione.
Can anyone tell me the ticker for Andrew Tate's brothers Taliban Human trafficking company called "Only Fans" ? I have some money to launder and the supplement market ain't what it used to be. Lol JK ......
If sp, can close above 10780, this would complete the third bullish pivot, since last trough. Also major uptrend line, would be restored from March 2021.
The equity in 10/7/23, provided an excellent buying opportunity, when the top Bollinger band turned down, as the lower Bollinger band continued to fall. Such a pattern seen, has more often than not shown opportunity to buy near a sp, bottom.
AstraZeneca reported strong first-half growth on Friday, despite challenges related to the decline of Covid-19 medicines. The FTSE 100 company said total revenue for the six months reached $22.3bn, representing a 4% increase. It noted that the growth was achieved despite a decline of $2.18bn attributed to Covid-19 medicines. Excluding the impact of Covid-19 medicines, AstraZeneca still reported a 16% increase in total revenue, and a 15% improvement in product sales. AstraZeneca said the strong performance extended across its various therapeutic areas, with oncology medicines seeing a 22% increase in total revenue, followed closely by cardiovascular, renal and metabolism (CVRM) at 20%, respiratory and immunology (R&I) at 10%, and rare disease at 12%. The firm also reported an encouraging improvement in core product sales gross margin, which stood at 83%, reflecting a three-percentage-point increase. Its core earnings per share jumped 21%, reaching $4.07, as the company maintained its interim dividend at 93 US cents. Looking ahead, AstraZeneca reiterated its guidance for the full year. "Each of our non-Covid-19 therapy areas saw double-digit revenue growth, with eight medicines delivering more than $1bn of revenue in the first half, demonstrating the strength of our business," said chief executive officer Pascal Soriot. "Several medicines grew rapidly including Ultomiris, Imfinzi/Imjudo and Farxiga, with revenues up 64%, 57% and 40% respectively." Soriot said AstraZeneca's pipeline momentum was continuing, with eight positive pivotal trials for its oncology medicines so far this year, adding that the company was encouraged by the positive data from 'TROPION-Lung01' - the first pivotal trial of datopotamab deruxtecan. "We look forward to sharing the data with the medical community at an upcoming medical congress and are proceeding to file the data with the US Food and Drug Administration."
NVG “ My 8 in front not looking so negative now ? ”…………LOL
Nice enough.
Easy money here. Get in before America opens 🚀🚀
Good results. Should claw back some of the downward drift of late 👍